AMA Journal of Ethics
@JournalofEthics
Examining #ethical issues facing students & clinicians. We are editorially independent; posts do not necessarily reflect AMA views/policies. RTs ≠ endorsements.
ID:119097749
http://journalofethics.org 02-03-2010 17:24:57
33,7K Tweets
11,4K Followers
2,0K Following
The #AMAJournalofEthics invites manuscripts for peer-review consideration that are original contributions on bioethics topics: spr.ly/6017wALVB
As humans shape our environment through agriculture, industrialization, globalization, and technology, ecologies, including their microbes, evolve and adapt. Read this letter from the editor by Olivia Kates, MD: spr.ly/6014wA2pj
As humans shape our environment through agriculture, industrialization, globalization, and technology, ecologies, including their microbes, evolve and adapt. Read this letter from the editor by Olivia Kates, MD: spr.ly/6017wA2PV
Dr Majd Alsoubani joins #EthicsTalk to discuss her article, coauthored with Drs Maya Nadimpalli and Shira Doron MD, “A How Should Health Care Respond to Threats Antimicrobial Resistance Poses to Workers?”: spr.ly/6014wA23M
Dr Christy Rentmeester joins #EthicsTalk to discuss her article: “Uptown Squirrel Does Not Eat That”: spr.ly/6013wA23L
Devin Hunt joins #EthicsTalk to discuss his article, coauthored with Olivia Kates, MD, “A Brief History of Antimicrobial Resistance”: spr.ly/6012wA2zk
Lloyd Duplechan joins #EthicsTalk to discuss health organizations’ responsibilities to protect employees and community members from AMR: spr.ly/6015wA2Jh
Resistance has dogged infectious disease treatment processes since we started using modern antimicrobials, write Devin Hunt and Olivia Kates, MD: spr.ly/6018wA2DQ
If you’re a health care professional, the #AMAJournalofEthics offers continuing education opportunities through the AMA Ed Hub™: spr.ly/6013wALPx
Antimicrobial resistance (AMR) is a looming pandemic and poor health outcomes will not be borne equitably argue Majd Alsoubani, MD, Maya L. Nadimpalli, PhD, MS, and Shira Doron MD: spr.ly/6018wAFhO
Patients living in low-and middle-income countries (LMICs) shoulder the greatest burden of infections caused by antimicrobial-resistant pathogens. Learn more in this article by Elizabeth Gulleen, MD and Margaret Lubwama, MBChB, MMed: spr.ly/6015wAFAb